Publications

2025 | Human Immunology

Profiling the genetic diversity of the HLA system in Mexico using 9-locus allele and haplotype frequencies from donors in the NMDP Mexico donor center.

Authors:

Madbouly A, Bashyal P, Banos A, Ramirez J, Whitaker C, Fernandez-Viña M, Springer B, Ybarra Y, Maiers M, Bolon YT

2025 | Transplantation and Cellular Therapy

Cytokine release syndrome and neurotoxicity following CD19 CAR-T in B-cell lymphoma.

Authors:

Shouval R, Strouse C, Kim S, Oloyede T, Ahmed S, Awan FT, Luan D, Bachanova V, Badar T, Bar M, Barba P, Beintinjaneh A, Cashen A, Dholaria B, Elsawy M, Ganguly S, Geethakumari PR, Greenbaum U, Hashmi H, Hill LC, Jain MD, Jain T, Kebriaei P, Kittai AS, Locke FL, Lulla PD, Mead E, McGuirk J, Mussetti A, Nishihori T, Olson AL, Pennisi M, Perales MA, Riedell PA, Saber W, Mirza AS, Magalhaes-Silverman M, Shpall EJ, Sorror M, Wudhikarn K, Turtle CJ, Moskop A, Pasquini MC

2025 | Genes and Immunity

Association between HLA genetics and SARS-CoV-2 infection in a large real-world cohort.

Authors:

Letovsky SI, Cao X, Hollenbach JA, Mack SJ, Maiers M

2025 | Blood Advances

Delayed T cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults.

Authors:

Perales MA, Riches M, He N, Martens MJ, Chemaly RF, Dandoy CE, Hill JA, Díaz MA, Hashmi S, Prockop S, Lazarus HM, Beitinjaneh AM, Hildebrandt GC, Auletta JJ, Szabolcs P

2025 | Computers in Biology and Medicine

Establishment of a machine learning-based prediction framework to assess trade-offs in decisions that affect post-HCT outcomes.

Authors:

Akdemir D, Auletta JJ, Bupp C, Maiers M, Bolon YT

2025 | American Journal of Hematology

Autologous transplant or CAR-T as consolidation options in MYC rearranged large B-cell lymphoma patients in remission after salvage treatments.

Authors:

Furqan F, Ahn KW, Kaur M, Patel J, Ansell S, Awan FT, Baird J, Bezerra E, Farooq U, Fung H, Khurana A, Lekakis L, Lutfi F, McCarty J, Mukherjee D, Nath R, Romancik J, Schuster SJ, Smith M, Winter A, Turtle C, Sauter C, Shadman M, Herrera A, Hamadani M

2025 | Transplantation and Cellular Therapy

Proceedings from the Reimagining Caregiver Workshop: Addressing caregiver requirements for hematopoietic cell transplant.

Authors:

Preussler JM, DeSalvo AM, Tweeten B, Klaphake J, Cody MR, McGhee PM, Dawson KS, Schoeppner K, Auletta JJ

2025 | Blood

Standard-of-care Idecabtagene Vicleucel for relapsed/refractory multiple myeloma: A CIBMTR analysis.

Authors:

Sidana S, Ahmed N, Akhtar OS, Brazauskas R, Oloyede T, Bye M, Hansen DK, Ferreri CJ, Freeman CL, Afrough A, Anderson LD Jr., Dhakal B, Dhanda DS, Gowda L, Hashmi H, Harrison MJ, Kitali A, Landau HJ, Mirza AS, Patwardhan P, Qazilbash MH, Usmani SZ, Patel KK, Nishihori T, Ganguly S, Pasquini MC

2025 | JCO Oncology Practice

Erratum: Rapid donor identification improves survival in high-risk first-remission patients with acute myeloid leukemia.

Authors:

Pagel JM, Othus M, Garcia-Manero G, Fang M, Radich JP, Rizzieri DA, Marcucci G, Strickland SA, Litzow MR, Savoie ML, Spellman SR, Confer DL, Chell JW, Brown M, Medeiros BC, Sekeres MA, Lin TL, Uy GL, Powell BL, Bayer R-L, Larson RA, Stone RM, Claxton D, Essell J, Luger SM, Mohan SR, Moseley A, Erba HP, Appelbaum FR

2025 | Blood Advances

Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704.

Authors:

Sorror ML, Saber W, Logan BR, Geller N, Bellach A, Kou J, Wood WA, McCarty J, Knight TG, Runaas L, Johnston LJ, Walston JD, Nakamura R, Jarrett L, Mishra A, Uberti J, Dahi PB, Saultz JN, McCurdy SR, Morris LE, Imus P, Hogan WJ, Nadiminti KVG, Bhatt VR, Olin RL, Maakaron J, Sobecks RM, Wall SA, Mattila D, Protz B, Devine SM, Horowitz MM, Artz AS

2025 | American Journal of Hematology

Donor age matters for haploidentical HCT patients even after adjusting for HLA factors: A machine learning approach.

2025 | EBioMedicine

Donor telomeres and their magnitude of shortening post-allogeneic haematopoietic cell transplant impact survival for patients with early-stage leukaemia or myelodysplastic syndrome.

Authors:

Gadalla SM, Katki HA, Lai TP, Auer PL, Dagnall CL, Bupp C, Hutchinson AA, Anderson JJ, Mendez KJW, Spellman SR, Steward V, Savage SA, Lee SJ, Levine JE, Saber W, Aviv A

2025 | Blood Advances

Transplant outcomes Using Older Matched Sibling Donors Compared to Young Alternative Donors: A CIBMTR Analysis.

Authors:

Nath K, Zhang MJ, Bye M, Abid MB, Benjamin C, Betts BC, Bhatt NS, Arrieta-Bolaños E, Bolon YT, Gadalla SM, Grunwald MR, Krem MM, Lee SJ, Marsh SGE, Martino R, Mehta PA, Milano F, Prestidge T, Saultz JN, Shaw BE, Spellman SR, Choe HK, Shaffer BC

2025 | American Journal of Human Genetics

Human leukocyte antigen variation is associated with cytomegalovirus serostatus in healthy individuals.

Authors:

Boquett JA, Sauter J, Schmidt AH, Maiers M, Hollenbach JA

2025 | NEJM Evidence

Haploidentical bone marrow transplantation for sickle cell disease.

Authors:

Kassim AA, Walters MC, Eapen M, Smith M, Logan BR, Solh MM, McKinney C, Nieder M, Ross M, Kent M, Abusin GA, Mallhi K, Silva JG, Shaughnessy P, Kanter J, Haines H, Farah R, Khaled YA, Ritzau N, Mendizabal A, Abraham A, Bollard C, Cooke K, de la Fuente J, Hanna R, Horowitz MM, Jordan LC, Bakshi N, Krishnamurti L, Leifer E, Mahadeo KM, Shenoy S, Jones RJ, DeBaun MR, Brodsky RA

2025 | American Journal of Hematology

Five-year real-world safety of Inotuzumab Ozogamicin before hematopoietic stem cell transplantation in B-cell precursor acute lymphoblastic leukemia.

Authors:

de Lima M, Kebriaei P, Lanza F, Cho C, Popradi G, Kaur M, Zhang MJ, Zhang F, Shah R, Vandendries E, Asomaning K, Dorman S, Stelljes M, Marks DI, Saber W

2025 | Leukemia

Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702

Authors:

Banerjee R, Fritz AR, Akhtar OS, Freeman CL, Cowan AJ, Shah N, Landau HJ, Kumar SK, Vogl DT, Efebera YA, McCarthy PL, Vesole DH, Mendizabal A, Krishnan AY, Somlo G, Stadtmauer EA, Pasquini MC

2025 | Journal for Immunotherapy of Cancer (JI...

Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry.

Authors:

Landsburg DJ, Frigault MJ, Heim M, Foley SR, Hill B, Schofield G, Jacobson CA, Jaglowski S, Locke FL, Ram R, Riedell PA, Shah G, Popplewell LL, Tiwari R, Lim S, Majdan M, Masood A, Pasquini MC

2025 | Haematologica

Utilization of allogeneic hematopoietic stem cell transplantation among patients with newly diagnosed acute myeloid leukemia in California: a population-based linked dataset study.

Authors:

Meyer CL, Keegan THM, Brunson A, Auletta JJ, Morton LM, Wun T, Schonfeld SJ, Valcarcel B, Abrahão R, Yusuf R, Muffly L

2025 | Blood Advances

Impact of vein-to-vein time in patients with R/R LBCL treated with axicabtagene ciloleucel.

Authors:

Locke FL, Siddiqi T, Jacobson CA, Nikiforow S, Ahmed S, Miklos DB, Lin Y, Lunning MA, Hill BT, Ghobadi A, Hu ZH, Hemmer MT, Zoratti MJ, Vunnum S, Tsang J, Spooner C, Smith H, Fu C, Patel AR, Miao H, Shahani SA, Mirjah DL, Xu H, Pasquini MC